- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06569914
Study on the Influence of Humanized Nursing Model on the Effect of Intravenous Infusion Care
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Forty patients who chose our hospital for intravenous infusion were included in the study. Randomly divide two groups using the numerical table method.Control group, 20 cases, receiving routine nursing care.Observation group, 20 cases, receiving humanized care.
Control group: Routine nursing, strict implementation of the "three checks and eight pairs" process, strict inspection of the quality of drugs used by patients, and strict adherence to medical advice on drug dosage.
Observation group: Humanized nursing includes humanized environmental care, humanized medical guidance, humanized psychological care, and humanized standardized management of IVGTT treatment process. The specific content is: (1) Humanized environmental care: Increase the frequency of cleaning the ward. If there is vomit or stagnant water, it should be removed as soon as possible to ensure that the ward floor is always kept clean and tidy, and to avoid patients falling due to water stains or foreign objects on the floor. Reasonably increase the number of garbage bins in the ward area. If conditions permit, place magazines, educational manuals, and other items in the ward that can help patients pass the time during the infusion process. (2) Humanized medical guidance: In addition to inquiring about the patient's allergy history and explaining the effects of medication before infusion, explain possible adverse reactions and corresponding treatment measures to the patient to avoid confusion, negative emotions or psychology after adverse reactions occur. If the patient does not have good vascular conditions, nursing staff can help massage the venous area before puncture, if the condition allows. Inform patients to pay attention to any adverse events (such as slipping of infusion set, redness and swelling of puncture site, etc.) during infusion, and immediately notify nursing staff if any are found. (3) Humanized psychological nursing: Many patients resist venipuncture, and nursing staff need to provide health education before IVGTT, so that patients understand the necessity and safety of IVGTT, improve patient cooperation, actively communicate with patients, understand their concerns about IVGTT, and provide timely and correct guidance; Remind family members to care for and encourage patients, so that they can actively cooperate with IVGTT. (4) Humanized and standardized management of IVGTT treatment process: One of the core tasks of nursing work is IVGTT. We strictly follow the hospital's nursing system for IVGTT treatment, strengthen training for nursing staff in terms of service attitude, social skills, puncture skills, etc., comprehensively improve the personal comprehensive literacy of nursing staff, and ensure that all nursing staff can perform venous puncture in a standardized and efficient manner.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
ZhengJiang
-
YiWu, ZhengJiang, China, 322000
- the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients receiving intravenous infusion in our hospital
- Have complete clinical data
- Know and sign the informed consent form
Exclusion Criteria:
- Underage patients
- Patients with consciousness and cognitive impairments
- Patients with mental illness
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: control group
Routine nursing:strict implementation of the "three checks and eight pairs" process, strict inspection of the quality of drugs used by patients, and strict adherence to medical advice on drug dosage.
|
|
|
Experimental: observation group
humanistic nursing:(1) Humanized environmental care;(2) Humanized medical guidance;(3)Humanized psychological nursing;(4) Humanized and standardized management of IVGTT treatment process
|
(1) Humanized environmental care;(2) Humanized medical guidance;(3)Humanized psychological nursing;(4) Humanized and standardized management of IVGTT treatment process
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hamilton Depression Scale
Time Frame: Up to 24 hours (during intravenous infusion)
|
Evaluate patients' psychological changes through the four indicators in the Hamilton Depression Scale (depression, mental anxiety, sleep disorders, and physical anxiety).
Each indicator ranges from 0 to 4 points, with 0 being the minimum value and 4 being the maximum value.
The better the patient's mentality, the lower the score.
|
Up to 24 hours (during intravenous infusion)
|
|
Self-made scale
Time Frame: Up to 24 hours (during intravenous infusion)
|
Evaluate patients' satisfaction with nursing services through five indicators in a self-made scale (environmental quality, reception attitude, puncture proficiency, health education quality, communication ability).
The range of each indicator is from 0 to 100 points, with 0 being the minimum value and 100 being the maximum value.
The higher the patient satisfaction, the higher the rating.
|
Up to 24 hours (during intravenous infusion)
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- KY-2024-141
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intravenous Infusion
-
BriovaRx Infusion ServicesTerminatedIntravenous Immunoglobulin (IVIg) Therapy in a Home Infusion SettingUnited States
-
The First Affiliated Hospital with Nanjing Medical...RecruitingObinutuzumab | Rapid Infusion | Intravenous Infusion ReactionChina
-
Assiut UniversityActive, not recruitingTotal Intravenous Anesthesia | Inhalational Anesthesia | Surgical Stress Response | Target-controlled InfusionEgypt
-
Istanbul UniversityRecruitingTotal Intravenous Anesthesia | Spinal (Fusion) Surgery | Target Controlled Infusion of Propofol | BIS-EEG | Anesthesia Depth MonitoringTurkey (Türkiye)
-
Smiths Medical, ASD, Inc.CompletedHome Healthcare Organizations Utilizing Ambulatory Infusion Pumps | Patients Requiring Infusion With an Ambulatory Infusion PumpUnited States
-
Soroka University Medical CenterBen-Gurion University of the NegevCompletedHome Infusion Therapy | Infusion PumpsIsrael
-
Optomeditech OyCardioMed Device Consultants, LLCCompletedA Trial to Demonstrate the Safety and Efficacy of the OptiVein IV Catheter In a Pediatric PopulationInjections, Intravenous | Administration, IntravenousEstonia
-
Herrick Medical LLCUniversity of Southern CaliforniaCompleted
-
Federal University of São PauloConselho Nacional de Desenvolvimento Científico e TecnológicoCompletedIntravenous Puncture Assertivity | Intravenous Puncture Guided by Vascular Ultrasound | Intravenous Therapy ComplicationsBrazil
-
SCRI Development Innovations, LLCAmgenCompleted
Clinical Trials on Humanized care
-
Zhejiang UniversityYake Biotechnology Ltd.RecruitingAcute Lymphoblastic Leukemia | Non-hodgkin Lymphoma,B CellChina
-
RemeGen Co., Ltd.RecruitingAdvanced Melanoma | Melanoma, Stage II | HER2-positiveChina
-
Memorial Sloan Kettering Cancer CenterY-mAbs TherapeuticsActive, not recruitingMelanoma | Sarcoma | NeuroblastomaUnited States
-
Gilead SciencesCompletedNon-Hodgkin's LymphomaUnited States
-
The First Affiliated Hospital of Soochow UniversityAffiliated Hospital of Jiangnan University; The Affiliated Nanjing Drum Tower... and other collaboratorsRecruiting
-
Goethe UniversityCompletedMetastatic Renal Cell CarcinomaSpain, Netherlands, United Kingdom, France, Germany, Czechia, Belgium
-
Fudan UniversityFujian Province Tumor Hospital; Ninth People's Hospital, Shanghai Jiao Tong... and other collaboratorsNot yet recruiting
-
Shanghai Mabgeek Biotech.Co.LtdNot yet recruitingAtopic Dermatitis | Atopic Eczema
-
Cancer Hospital Chinese Academy of Medical Science...Affiliated Cancer Hospital of Shantou University Medical College; The University...Not yet recruiting
-
Peking University People's HospitalRecruitingBreast Cancer | Collagen ProteinChina